14773506 · Active · incorporated 3 years, 6 months ago · Cambridge
Biotech Drug Discovery Healthcare Platform Series A
RNAvate specialises in developing novel RNA medicines and therapeutics based on stable, next-generation RNA molecules.
Rnavate is a private limited company registered at Companies House under number 14773506, incorporated on 31 March 2023, with a registered office in Cambridge. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 26 filings for this company, including 1 funding round. Its most recent round closed in November 2023, raising £4.7m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 1 | Nov 2023 | £4.7m | £225.83 |
Showing the 10 most recent of 26 filings.
See the complete cap table with every shareholder, founder tags, dilution across 7 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.